ICU Medical, Inc.

ICUI Healthcare Medical Instruments & Supplies

ICU Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.2 billion, down 6.33% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS fell 46.9%, free cash flow grew 656.0% and total debt fell 7.96%, each against the same quarter a year earlier.

162.99 4.24 −2.54%
Market cap
$4.2B
P/E
136×
Fwd P/E
49.5×
Dividend yield
—
F-score
6/9
Altman Z
2.12
Beneish M
−2.65
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

7 6 6 6
ROE
(0.35%) 0.04% 2.26% 1.41%
ROA
(0.18%) 0.02% 1.13% 0.74%
ROIC
1.49% 0.86% 0.88% 1.46%
Return on Tangible Assets
(0.63%) 0.06% 4.06% 2.60%
Average Days of Receivables
30.13 29.53 34.03 31.02
Free Cash Flow per Share
2.52 3.69 3.31 6.12
Free Cash Flow
62.33 90.89 82.08 152.88
Other line items

Show all line items

Columns are period end dates